Literature DB >> 329990

Possibilities, limitations, and technique for the study of regional myocardial perfusion in man by Xenon-133.

A Maseri, A L'abbate, C Michelassi, A Pesola, P Pisani, M Marzilli, M De Nes, P Mancini.   

Abstract

The theoretical possibilities and the practical limitations of the Xenon-133 (133Xe) method for the study of regional myocardial perfusion in man are discussed. The techniques for data acqusition and processing developed over the past 5 years are described in detail. Illustrative examples of experimental findings are reported. The practical interpretation of the data, at the light of the influence of injection site, initial tracer distribution, constancy of counting geometry, spatial resolution, and Xenon retention in fat, is presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 329990     DOI: 10.1093/cvr/11.4.277

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

1.  Measurement of regional myocardial perfusion using collimated miniature radiation detectors and the method of 133-xenon washout.

Authors:  F S Castellana; M I Friedman; R B Case
Journal:  Ann Biomed Eng       Date:  1983       Impact factor: 3.934

2.  The imaging of myocardial perfusion with 81mKr during coronary arteriography.

Authors:  P H Kleynhans; M G Lötter; A van Aswegen; C P Herbst; J D Marx; P C Minnaar
Journal:  Eur J Nucl Med       Date:  1982

3.  External quantification of myocardial perfusion by exponential infusion of positron-emitting radionuclides.

Authors:  S N Hack; J O Eichling; S R Bergmann; M J Welch; B E Sobel
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

4.  Myocardial perfusion measured by dual-isotope acquisition of 81rubidium/81mkrypton: an experimental verification of the method.

Authors:  H P Stoll; W Bay; W Vogel; C Ozbek; A Hanser; H Schieffer; G Harbauer
Journal:  Basic Res Cardiol       Date:  1994 Jul-Aug       Impact factor: 17.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.